Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable safety profile and ...

At the 2026 NCCN Annual Meeting, CURE sat down with Dr. Thomas Flaig to discuss the rapidly evolving landscape of bladder ...

A new set of drugs exploit a recently revealed weakness in "zombie-like"—or senescent—cells that could lead to new treatments ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses ...

In Iowa, one of the few states where cancer rates are increasing, there's more awareness that patients may need more mental health support during treatment and also after it ends.

Breath of Hope Ohio, which has raised more than $1.6 million for lung cancer research, will host its annual gala on May 2.

A Louisiana bill aimed at removing dental barriers to serious medical treatment advanced from committee after lawmakers said ...